|
1
|
Mehta RL, Cerda J, Burdmann EA, Tonelli M,
García-García G, Jha V, Susantitaphong P, Rocco M, Vanholder R,
Sever MS, et al: International society of nephrology's 0 by 25
initiative for acute kidney injury (zero preventable deaths by
2025): A human rights case for nephrology. Lancet. 385:2616–2643.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rewa O and Bagshaw SM: Acute kidney
injury-epidemiology, outcomes and economics. Nat Rev Nephrol.
10:193–207. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang L, Xing G, Wang L, Wu Y, Li S, Xu G,
He Q, Chen J, Chen M, Liu X, et al: Acute kidney injury in China: A
cross-sectional survey. Lancet. 386:1465–1471. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jha V and Parameswaran S:
Community-acquired acute kidney injury in tropical countries. Nat
Rev Nephrol. 9:278–290. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cerda J, Bagga A, Kher V and Chakravarthi
RM: The contrasting characteristics of acute kidney injury in
developed and developing countries. Nat Clin Pract Nephrol.
4:138–153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chawla LS, Amdur RL, Amodeo S, Kimmel PL
and Palant CE: The severity of acute kidney injury predicts
progression to chronic kidney disease. Kidney Int. 79:1361–1369.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zuk A and Bonventre JV: Acute kidney
injury. Annu Rev Med. 67:293–307. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Makris K and Spanou L: Acute kidney
injury: Definition, pathophysiology and clinical phenotypes. Clin
Biochem Rev. 37:85–98. 2016.PubMed/NCBI
|
|
9
|
Friedewald JJ and Rabb H: Inflammatory
cells in ischemic acute renal failure. Kidney Int. 66:486–491.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bonventre JV and Zuk A: Ischemic acute
renal failure: An inflammatory disease? Kidney Int. 66:480–485.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu L, Chen C, Zhang J, Wu K, Zhang X, Liu
H and Hou J: IL-35 pretreatment alleviates
lipopolysaccharide-induced acute kidney injury in mice by
inhibiting NF-κB activation. Inflammation. 40:1393–1400. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zuk A, Gershenovich M, Ivanova Y,
MacFarland RT, Fricker SP and Ledbetter S: CXCR4
antagonism as a therapeutic approach to prevent acute kidney
injury. Am J Physiol Renal Physiol. 307:F783–F797. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gigliotti JC, Huang L, Ye H, Bajwa A,
Chattrabhuti K, Lee S, Klibanov AL, Kalantari K, Rosin DL and Okusa
MD: Ultrasound prevents renal ischemia-reperfusion injury by
stimulating the splenic cholinergic anti-inflammatory pathway. J Am
Soc Nephrol. 24:1451–1460. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Castoldi A, Braga TT, Correa-Costa M,
Aguiar CF, Bassi ÊJ, Correa-Silva R, Elias RM, Salvador F,
Moraes-Vieira PM, Cenedeze MA, et al: TLR2, TLR4 and the MYD88
signaling pathway are crucial for neutrophil migration in acute
kidney injury induced by sepsis. PLoS One. 7:e375842012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gluba A, Banach M, Hannam S, Mikhailidis
DP, Sakowicz A and Rysz J: The role of Toll-like receptors in renal
diseases. Nat Rev Nephrol. 6:224–235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alves-Filho JC, Freitas A, Souto FO,
Spiller F, Paula-Neto H, Silva JS, Gazzinelli RT, Teixeira MM,
Ferreira SH and Cunha FQ: Regulation of chemokine receptor by
Toll-like receptor 2 is critical to neutrophil migration and
resistance to polymicrobial sepsis. Proc Natl Acad Sci USA.
106:4018–4023. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peng Y, Zhang X, Wang Y, Li S, Wang J and
Liu L: Overexpression of toll-like receptor 2 in glomerular
endothelial cells and podocytes in septic acute kidney injury mouse
model. Ren Fail. 37:694–698. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng Y, Zhang X, Wang Y, Yuan H, Zhang S
and Liu L: Toll like receptor 2 induces kidney inflammation via
MyD88/NF-κB signaling pathway. Int J Clin Exp Med. 11:3494–3503.
2018.
|
|
19
|
Chen Y, Lin L, Tao X, Song Y, Cui J and
Wan J: The role of podocyte damage in the etiology of
ischemia-reperfusion acute kidney injury and post-injury fibrosis.
BMC Nephrol. 20:1062019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Perkin WH and Robinson R: CCXXII. - Some
derivatives of ortho-vanillin. J Chem Soc Transactions.
105:2376–2392. 1914. View Article : Google Scholar
|
|
21
|
Mistry P, Laird MH, Schwarz RS, Greene S,
Dyson T, Snyder GA, Xiao TS, Chauhan J, Fletcher S, Toshchakov VY,
et al: Inhibition of TLR2 signaling by small molecule inhibitors
targeting a pocket within the TLR2 TIR domain. Proc Natl Acad Sci
USA. 112:5455–5460. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rueden CT, Schindelin J, Hiner MC, DeZonia
BE, Walter AE, Arena ET and Eliceiri KW: ImageJ2: ImageJ for the
next generation of scientific image data. BMC Bioinformatics.
18:5292017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu L, Chen C, Zhang J, Wu K, Zhang X, Liu
H and Hou J: IL-35 Pre-treatment alleviates
lipopolysaccharide-induced acute kidney injury in mice by
inhibiting NF-κB activation. Inflammation. 40:1393–1400. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Yin H, Zhao M and Lu Q: TLR2 and
TLR4 in autoimmune diseases: A comprehensive review. Clin Rev
Allergy Immunol. 47:136–147. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chawla LS, Seneff MG, Nelson DR, Williams
M, Levy H, Kimmel PL and Macias WL: Elevated plasma concentrations
of IL-6 and elevated APACHE II score predict acute kidney injury in
patients with severe sepsis. Clin J Am Soc Nephrol. 2:22–30. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Paladino JD, Hotchkiss JR and Rabb H:
Acute kidney injury and lung dysfunction: A paradigm for remote
organ effects of kidney disease? Microvasc Res. 77:8–12. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu C, Chang A, Hack BK, Eadon MT, Alper SL
and Cunningham PN: TNF-mediated damage to glomerular endothelium is
an important determinant of acute kidney injury in sepsis. Kidney
Int. 85:72–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ajuwon KM and Spurlock ME: Adiponectin
inhibits LPS-induced NF-kappaB activation and IL-6 production and
increases PPARgamma2 expression in adipocytes. Am J Physiol Regul
Integr Comp Physiol. 288:R1220–F1225. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cascinu S, Scartozzi M, Carbonari G,
Pierantoni C, Verdecchia L, Mariani C, Squadroni M, Antognoli S,
Silva RR, Giampieri R and Berardi R: COX-2 and NF-κB overexpression
is common in pancreatic cancer but does not predict for COX-2
inhibitors activity in combination with gemcitabine and
oxaliplatin. Am J Clin Oncol. 30:526–530. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zarjou A and Agarwal A: Sepsis and acute
kidney injury. J Am Soc Nephrol. 22:999–1006. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Grigoryev DN, Liu M, Hassoun HT, Cheadle
C, Barnes KC and Rabb H: The local and systemic inflammatory
transcriptome after acute kidney injury. J Am Soc Nephrol.
19:547–558. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ye HY, Jin J, Jin LW, Chen Y, Zhou ZH and
Li ZY: Chlorogenic acid attenuates lipopolysaccharide-induced acute
kidney injury by inhibiting TLR4/NF-κB signal pathway.
Inflammation. 40:523–529. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dorak MT: Basic immunology: Functions and
disorders of the immune system. Am J Epidemiol. 155:185–186. 2012.
View Article : Google Scholar
|
|
34
|
Gustafson GL and Rhodes MJ: A rationale
for the prophylactic use of monophosphoryl lipid A in sepsis and
septic shock. Biochem Biophys Res Commun. 182:269–275. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Poelstra K, Bakker WW, Klok PA, Hardonk MJ
and Meijer DK: A physiologic function for alkaline phosphatase:
Endotoxin detoxification. Lab Invest. 76:319–327. 1997.PubMed/NCBI
|
|
36
|
Cavaillon JM, Adib-Conquy M, Fitting C,
Adrie C and Payen D: Cytokine cascade in sepsis. Scand J Infect
Dis. 35:535–544. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cunningham PN, Ying W, Guo R, Gang H and
Quigg RJ: Role of toll-like receptor 4 in endotoxin-induced acute
renal failure. J Immunol. 172:2629–2635. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fiedler VB, Loof I, Sander E, Voehringer
V, Galanos C and Fournel MA: Monoclonal antibody to tumor necrosis
factor-alpha prevents lethal endotoxin sepsis in adult rhesus
monkeys. J Lab Clin Med. 120:574–588. 1992.PubMed/NCBI
|
|
39
|
Pasquet V, Perwuelz A, Behary N and Isaad
J: Vanillin, a potential carrier for low temperature dyeing of
polyester fabrics. J Cleaner Product. 43:20–26. 2013. View Article : Google Scholar
|
|
40
|
Shmuel-Galia L, Aychek T, Fink A, Porat Z,
Zarmi B, Bernshtein B, Brenner O, Jung S and Shai Y: Neutralization
of pro-inflammatory monocytes by targeting TLR2 dimerization
ameliorates colitis. EMBO J. 35:685–698. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Landais I, Pelton C, Streblow D,
DeFilippis V, McWeeney S and Nelson JA: Human Cytomegalovirus
miR-UL112-3p targets TLR2 and modulates the TLR2/IRAK1/NFκB
signaling pathway. PLoS Pathog. 11:e10048812015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Koymans KJ, Feitsma LJ, Brondijk TH, Aerts
PC, Lukkien E, Lössl P, van Kessel KP, de Haas CJ, van Strijp JA
and Huizinga EG: Structural basis for inhibition of TLR2 by
staphylococcal superantigen-like protein 3 (SSL3). Proc Natl Acad
Sci USA. 112:11018–11023. 2015. View Article : Google Scholar : PubMed/NCBI
|
